However, some studies have shown that treatment with suberoylanilide hydroxamic acid (SAHA), an acetylase inhibitor, can significantly induce apoptosis in HCC cells through mechanisms other than the overexpression of Bcl-2. The gene discussed is BCL2; the disease is hepatocellular carcinoma.